New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
13:21 EDTINOInovio says ITT analysis achieved statistical significance in VGX-3100 trial
Inovio Pharmaceuticals disclosed in a regulatory filing that it supplemented the information included in its press release issued earlier today about its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 associated with human papillomavirus types 16 or 18 by announcing through an electronic media statement that per protocol analysis measured subjects who received 3 doses of a 3-dose regimen. "An ITT, or intent-to-treat analysis, also achieved statistical significance," the company stated.
News For INO From The Last 14 Days
Check below for free stories on INO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
12:08 EDTINOOptions with increasing implied volatility
Subscribe for More Information
September 4, 2014
11:05 EDTINOOptions with increasing implied volatility
Subscribe for More Information
09:02 EDTINOInovio to list on NASDAQ
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use